May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
Doxycycline's Effect on the Angiogenic Potential of Pterygial Epithelial Cells
C.A. Cox; A. Martinez; T.W. Reid; N. Dushku; C. Jaworski; M. John–Aryankalayil; D.A. Carper
Author Affiliations & Notes
  • C.A. Cox
    Section of Molecular Therapeutics, National Eye Institute, Bethesda, MD
  • A. Martinez
    National Cancer Institute, Bethesda, MD
  • T.W. Reid
    Ophthalmology and Visual Sciences and Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX
  • N. Dushku
    Kaiser Permanente Medical Center, Sacramento, CA
  • C. Jaworski
    Section of Molecular Therapeutics, National Eye Institute, Bethesda, MD
  • M. John–Aryankalayil
    National Cancer Institute, Bethesda, MD
  • D.A. Carper
    Section of Molecular Therapeutics, National Eye Institute, Bethesda, MD
  • Footnotes
    Commercial Relationships  C.A. Cox, None; A. Martinez, None; T.W. Reid, None; N. Dushku, None; C. Jaworski, None; M. John–Aryankalayil, None; D.A. Carper, None.
  • Footnotes
    Support  None.
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 959. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      Doxycycline's Effect on the Angiogenic Potential of Pterygial Epithelial Cells
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      C.A. Cox, A. Martinez, T.W. Reid, N. Dushku, C. Jaworski, M. John–Aryankalayil, D.A. Carper; Doxycycline's Effect on the Angiogenic Potential of Pterygial Epithelial Cells . Invest. Ophthalmol. Vis. Sci. 2005;46(13):959.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Abstract: : Purpose: To determine the angiogenic potential of human pterygial epithelial cells and doxycycline's effect on neovascularization induced by these cells using the directed in vivo angiogenesis assay (DIVAA). Methods: The angiogenic potential of fourth passage human pterygial epithelial cells was compared with basic fibroblast growth factor (bFGF) in Matrigel for a positive control and PBS in Matrigel for a negative control using DIVAA (approved NCI animal protocol). In this assay, silicone capsules (angioreactors) containing Matrigel with PBS, bFGF or 10,000 human pterygial epithelial cells were implanted under the skin of anesthetized nude mice. After 11 days, fluorescein isothiocyanate–dextran (FITC–d) was injected into the tail veins of the mice, and ten minutes later they were euthanized and the extent of neovascularization was quantified using a spectrofluorimeter (excitation 485 nm, emission 510 nm.). The mean relative fluorescence for six replicates was determined; Student's t–test was used to analyze the data. In a separate DIVAA experiment, doxycycline at three different concentrations was added to the angioreactors in combination with pterygial cells to determine the effect on angiogenesis. Six replicates were compared for each group as above.Results:Human pterygial epithelial cells were significantly angiogenic when compared to Matrigel with PBS (p<0.01) and Matrigel with bFGF (p<0.05). Doxycycline significantly inhibited angiogenesis in the mid–concentration (500 micrograms/ml) p=0.003, but not in the lowest or highest concentrations.Conclusions: Human pterygial epithelial cells were very angiogenic using an in vivo model, and a mid–range dose of doxycycline inhibited neovascularization in this model. This may eventually be beneficial to patients' vision by reducing the growth and/or recurrence of not only pterygia, but other angiogenic ocular diseases.

Keywords: Pterygium • neovascularization • pharmacology 
© 2005, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2025 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept